1. Pink Sheet
  2. >>Geography

What Would You Do? Regulatory Staff Consider Some Tough Tests

 
• By Ian Schofield

Delegates and experts were faced with some difficult choices during a session at this year's TOPRA annual symposium.

Businessman looking and thinkin front of a chalkboard brick wall with the complicated solution from point A to point B
Regulatory decisions are not always straightforward • Source: Alamy

One of the most entertaining sessions at this year’s TOPRA (The Organization for Professionals in Regulatory Affairs) symposium saw delegates and speakers presented with a series of tricky regulatory scenarios and invited to say what action they would take in each case.

Entitled “Avoiding disastrous mistakes with an effective regulatory strategy,” the session was aimed at company personnel such as regulatory affairs...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography

Industry Criticizes Dutch Decision To Slash PARP Inhibitor Reimbursement

 
• By Francesca Bruce

ZIN, the Dutch health technology assessment body, estimates that the number of patients eligible for treatment with a PARP inhibitor will be halved following a reassessment of drugs in the class.

EU Biosimilar Filings, Opinions And Approvals

 
• By Neena Brizmohun

A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.

US FDA’s ADHD Drug Relabeling Advances A MAHA Priority, Reviving Data Dispute

 
• By Bridget Silverman

Extended-release stimulants will add a new ‘Limitation of Use’ about weight loss in children under 6 years, reflecting concerns about overuse from the Make America Healthy Again commission, a concern multiple studies did not find valid.